HIKMA PHARMACEUTICALS (HKMPY)

47.70
0.80 1.71
OTC
Prev Close 46.90
Open 47.70
Day Low/High 47.70 / 47.70
52 Wk Low/High 35.95 / 52.40
Volume 100.00
Exchange OTC
Shares Outstanding 241.46B
Market Cap 5.30B
Div & Yield N.A. (N.A)

Latest News

Hikma Demonstrates Support For US Pharmacists And Patient Safety

Hikma Demonstrates Support For US Pharmacists And Patient Safety

Hikma Pharmaceuticals USA Inc., a wholly owned subsidiary of Hikma Pharmaceuticals PLC ("Hikma") (LSE:HIK) (NASDAQ Dubai:HIK) (OTC:HKMPY), the multinational generic pharmaceutical company, will demonstrate its commitment to serving the needs of US...

Hikma Acts To Ease Critical Shortage Of Pain Medications Needed By US Hospitals And Their Patients

Hikma Acts To Ease Critical Shortage Of Pain Medications Needed By US Hospitals And Their Patients

Hikma Pharmaceuticals PLC (the Hikma Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the multinational generic pharmaceutical company, announced today that its US business has begun releasing significant quantities of hydromorphone to US hospital...

European Stocks Sink on Trump Woes and FOMC Minutes

European Stocks Sink on Trump Woes and FOMC Minutes

Fed confusion and the 'Game of Thrones' in the White House dragged markets lower.

Hikma Sinks on Advair Generic Concerns

Hikma Sinks on Advair Generic Concerns

Hikma lowered its guidance and failed to concerns over Advair generic

Bank Stocks Hit By Fed Minutes As European Markets Fall

Bank Stocks Hit By Fed Minutes As European Markets Fall

Earnings also sent some stocks into a spiral

GSK Stock Falls on Reduced Guidance

GSK Stock Falls on Reduced Guidance

Higher investment in HIV led GSK to cut earnings guidance

Bank Stocks Help Lift Europe's Benchmarks to Solid Gains

Bank Stocks Help Lift Europe's Benchmarks to Solid Gains

The rescue of two failing Italian lenders helped to lift European benchmarks higher Monday, with solid gains for lenders in Southern Europe in particular.

Hikma Shakes Up U.S. Operations After FDA Disappointment; CEO Said Darwazah to Lead Group

Hikma Shakes Up U.S. Operations After FDA Disappointment; CEO Said Darwazah to Lead Group

Hikma shares were active in London trading Monday after the drugmaker unveiled a reorganization of its U.S. business that includes a change in leadership.

European Stocks Rebound Following Trump Rout

European Stocks Rebound Following Trump Rout

European stocks rebounded Friday as investors shook off the pessimism of recent days, with price action supported by both M&A as well as corporate earnings news.

European Stocks Gain, Oil Tests One-Month Highs as Risk Sentiment Recovers

European Stocks Gain, Oil Tests One-Month Highs as Risk Sentiment Recovers

European stocks rose firmly higher in the opening hour of trading Friday as global financial markets attempted to claw back losses from a volatile week of trading.

Hikma Trims Full-Year Revenue Guidance After Advair Diskus Delay

Hikma Trims Full-Year Revenue Guidance After Advair Diskus Delay

Hikma Pharmaceuticals lowered its full year revenue guidance Friday after the U.S. Food & Drug Administration expressed concern over its generic Advair Diskus product.

European Benchmarks Slump as Washington Jilts Markets

European Benchmarks Slump as Washington Jilts Markets

European stocks slumped Wednesday as the latest skirmish in Washington, over President Donald Trump's unorthodox stewardship of the Oval Office left markets jilted.

Huge Downgrades Loom Over Hikma Pharmaceuticals

Huge Downgrades Loom Over Hikma Pharmaceuticals

Hikma could get hit with sizeable downgrades Friday when it updates the market with new guidance in the wake of the FDA's rejection of its generic Advair Diskus product

European Stocks Down as Earnings Open Floodgates of Disappointment

European Stocks Down as Earnings Open Floodgates of Disappointment

Most major benchmarks were down Thursday, with Madrid and Frankfurt the deepest in the red, while London bucked the trend thanks to a weaker sterling

Hikma Shares Plunge After It Says 'Low Likelihood' of 2017 Generic Advair Approval

Hikma Shares Plunge After It Says 'Low Likelihood' of 2017 Generic Advair Approval

Hikma shares plunged the most in nine months inLondon trading Thursday after the drugmaker said that approval of its generic Advair Diskus asthma treatment faces delays from the FDA.

European Stocks See Mixed Session as U.K.'s FTSE Leads

European Stocks See Mixed Session as U.K.'s FTSE Leads

European stock markets were mixed Wednesday's as investors responded to yet another raft earnings reports, company statements and comments from policy makers across the continent.

Hikma Shares Slide Amid Speculation of FDA Ruling on Generic Advair

Hikma Shares Slide Amid Speculation of FDA Ruling on Generic Advair

Hikma Pharmaceuticals fell sharply in London ahead of a crucial decision by the U.S. Food & Drug Administration on whether to approve its generic Advair asthma treatment.

European Benchmarks Lifted by Sluice of Strong Corporate Earnings

European Benchmarks Lifted by Sluice of Strong Corporate Earnings

From automakers to financials, strong corporate earnings numbers helped to boost major European benchmarks Wednesday, although stocks in Southern Europe fell on concerns over bank capital

Glaxo Stock Slumps as Investors Eye Advair Generics

Glaxo Stock Slumps as Investors Eye Advair Generics

Mylan's setback may not be enough to prevent generic Advair reaching the market in 2017

European Stocks High on French Perfume and Trump Bump

European Stocks High on French Perfume and Trump Bump

M&A, French election relief and renewed talk of reforms to taxes and trade all helped to push European stocks higher Tuesday

European Stocks See Red After Terror Strikes Again

European Stocks See Red After Terror Strikes Again

Markets were buoyant throughout much of the session but turned sharply lower after terror struck the subway system in St Petersburg

Europe Benchmarks Sank by Perfect Cocktail of Risk and Uncertainty

Europe Benchmarks Sank by Perfect Cocktail of Risk and Uncertainty

Unease over the outlook for global trade, monetary policies and politica stability torpedoed markets from early on Tuesday

European Markets Rebound Ahead of The Fed

European Markets Rebound Ahead of The Fed

A rebound in commodities and expectations of a Fed rate hike helped to drive markets higher

European Stocks Hold Gains, Oil Rebounds Firmly Ahead of Fed Rate Decision

European Stocks Hold Gains, Oil Rebounds Firmly Ahead of Fed Rate Decision

European stocks held onto modest gains Wednesday as investors set positions ahead of a key rate decision from the U.S. Federal Reserve and results from national elections in the Netherlands.

Hikma Shares Surge After Bullish 2017 Outlook For Generic Drug Sales

Hikma Shares Surge After Bullish 2017 Outlook For Generic Drug Sales

Hikma Pharmaceuticals shares surged to a seven-month high Wednesday after the generic drugmaker said new products and stronger sales will boost 2017 earnings.

European Stocks Mixed as Frankfurt Rises, Paris Falls

European Stocks Mixed as Frankfurt Rises, Paris Falls

The Dax rose following a strong performance from the automotive sector, but both London and Paris slumped.

Glaxo Beats Expectations for Fourth-Quarter Earnings; Shares Fall on Advair Concerns

Glaxo Beats Expectations for Fourth-Quarter Earnings; Shares Fall on Advair Concerns

GlaxoSmithKline beat analysts' expectations for fourth-quarter sales and earnings Wednesday but warned of a significant hit this year from anticipated generic competition to its Advair asthma treatment.

Earnings Preview: GlaxoSmithKline Likely to See Currency Boost; Advair Sales in Focus

Earnings Preview: GlaxoSmithKline Likely to See Currency Boost; Advair Sales in Focus

GlaxoSmithKline reports fourth-quarter earnings Wednesday, with investors looking for guidance on the fate of its key Advair drug and the recent pace of organic growth for new products sales.